Development and Use of Patient Experience Data
This article was originally published in RPM Report
Executive Summary
Here is an excerpt from the House “21st Century Cures” bill defining the key elements of a new process to collect “patient experience data,” under Title II, Subtitle A, “Patient-Focused Drug Development.”